Krystal Biotech, Inc. KRYS Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s total current assets?
- Krystal Biotech, Inc. (KRYS) reported total current assets of $1.02B in Q1 2026.
- How has Krystal Biotech, Inc.'s total current assets changed year-over-year?
- Krystal Biotech, Inc.'s total current assets increased by 33.0% year-over-year, from $766.8M to $1.02B.
- What is the long-term trend for Krystal Biotech, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s total current assets has grown at a 30.1% compound annual growth rate (CAGR), from $275.06M to $1.02B.
- What does total current assets mean?
- The total value of all assets the company can turn into cash within one year.
- How do you interpret total current assets?
- An increase generally indicates a stronger liquidity position, while a decrease may signal potential funding or operational challenges.
- How does total current assets compare across companies?
- Standard across all industries; essential for comparing the financial runway of peer biotech companies.